(NASDAQ: ICUI) Icu Medical's forecast annual revenue growth rate of 4.4% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 10.37%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.18%.
Icu Medical's revenue in 2026 is $2,156,785,000.On average, 9 Wall Street analysts forecast ICUI's revenue for 2026 to be $55,435,771,530, with the lowest ICUI revenue forecast at $52,811,445,105, and the highest ICUI revenue forecast at $57,860,149,275. On average, 9 Wall Street analysts forecast ICUI's revenue for 2027 to be $57,935,130,030, with the lowest ICUI revenue forecast at $54,885,912,660, and the highest ICUI revenue forecast at $60,559,456,455.
In 2028, ICUI is forecast to generate $61,734,154,950 in revenue, with the lowest revenue forecast at $58,959,867,015 and the highest revenue forecast at $63,933,590,430.